Is this still being done this week Per the PR?
Post# of 36537
Mr. Moscato continued, “With the dividend being paid next week, and our Generex S-1 registration statement filed, we can now execute fully on our plans.
This part ***************
As a first step next week, we will be filing an S-1 for the spin out of NuGenerex Immuno-Oncology, with goal of listing directly onto the Nasdaq. With the S-1 funding, our subsidiaries can increase manufacturing, sales & marketing, and distribution of our revenue generating products
********